Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade

被引:403
作者
Benci, Joseph L. [1 ,7 ,8 ,15 ]
Johnson, Lexus R. [1 ,8 ]
Choa, Ruth [4 ]
Xu, Yuanming [1 ,8 ]
Qiu, Jingya [1 ,8 ]
Zhou, Zilu [9 ]
Xu, Bihui [1 ,8 ]
Ye, Darwin [1 ,8 ]
Nathanson, Katherine L. [2 ,6 ]
June, Carl H. [4 ,6 ,7 ,8 ]
Wherry, E. John [3 ,5 ,6 ,7 ]
Zhang, Nancy R. [9 ]
Ishwaran, Hemant [10 ]
Hellmann, Matthew D. [11 ,12 ,14 ]
Wolchok, Jedd D. [11 ,12 ,13 ,14 ]
Kambayashi, Taku [4 ,6 ]
Minn, Andy J. [1 ,6 ,7 ,8 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA
[6] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA
[7] Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA
[8] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
[9] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA
[10] Univ Miami, Dept Epidemiol & Publ Hlth, Div Biostat, Miami, FL 33136 USA
[11] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA
[12] Mem Sloan Kettering Canc Ctr, Parker Inst Canc Immunotherapy, New York, NY 10065 USA
[13] Mem Sloan Kettering Canc Ctr, Ludwig Collaborat Lab, New York, NY 10065 USA
[14] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA
[15] Bristol Myers Squibb, Princeton, NJ 08540 USA
关键词
NATURAL-KILLER-CELLS; I INTERFERON; PD-1; BLOCKADE; NK CELLS; CLINICAL-RESPONSE; LYMPHOID-CELLS; TUMOR-CELLS; RESISTANCE; MELANOMA; THERAPY;
D O I
10.1016/j.cell.2019.07.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Interferon-gamma (IFNG) augments immune function yet promotes T cell exhaustion through PDL1. How these opposing effects are integrated to impact immune checkpoint blockade (ICB) is unclear. We show that while inhibiting tumor IFNG signaling decreases interferon-stimulated genes (ISGs) in cancer cells, it increases ISGs in immune cells by enhancing IFNG produced by exhausted T cells (T-EX). In tumors with favorable antigenicity, these T-EX mediate rejection. In tumors with neoantigen or MHC-I loss, T-EX instead utilize IFNG to drive maturation of innate immune cells, including a PD1(+)TRAIL(+) ILC1 population. By disabling an inhibitory circuit impacting PD1 and TRAIL, blocking tumor IFNG signaling promotes innate immune killing. Thus, interferon signaling in cancer cells and immune cells oppose each other to establish a regulatory relationship that limits both adaptive and innate immune killing. In melanoma and lung cancer patients, perturbation of this relationship is associated with ICB response independent of tumor mutational burden.
引用
收藏
页码:933 / +
页数:30
相关论文
共 57 条
[1]
Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa-Dependent Manner [J].
Ahlenstiel, Golo ;
Titerence, Rachel H. ;
Koh, Christopher ;
Edlich, Birgit ;
Feld, Jordan J. ;
Rotman, Yaron ;
Ghany, Marc G. ;
Hoofnagle, Jay H. ;
Liang, T. Jake ;
Heller, Theo ;
Rehermann, Barbara .
GASTROENTEROLOGY, 2010, 138 (01) :325-335
[2]
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade [J].
Ayers, Mark ;
Lunceford, Jared ;
Nebozhyn, Michael ;
Murphy, Erin ;
Loboda, Andrey ;
Kaufman, David R. ;
Albright, Andrew ;
Cheng, Jonathan D. ;
Kang, S. Peter ;
Shankaran, Veena ;
Piha-Paul, Sarina A. ;
Yearley, Jennifer ;
Seiwert, Tanguy Y. ;
Ribas, Antoni ;
McClanahan, Terrill K. .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (08) :2930-2940
[3]
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade [J].
Benci, Joseph L. ;
Xu, Bihui ;
Qiu, Yu ;
Wu, Tony J. ;
Dada, Hannah ;
Twyman-Saint Victor, Christina ;
Cucolo, Lisa ;
Lee, David S. M. ;
Pauken, Kristen E. ;
Huang, Alexander C. ;
Gangadhar, Tara C. ;
Amaravadi, Ravi K. ;
Schuchter, Lynn M. ;
Feldman, Michael D. ;
Ishwaran, Hemant ;
Vonderheide, Robert H. ;
Maity, Amit ;
Wherry, E. John ;
Minn, Andy J. .
CELL, 2016, 167 (06) :1540-+
[4]
Random forests [J].
Breiman, L .
MACHINE LEARNING, 2001, 45 (01) :5-32
[5]
Random forests for genomic data analysis [J].
Chen, Xi ;
Ishwaran, Hemant .
GENOMICS, 2012, 99 (06) :323-329
[6]
Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs [J].
Cheng, Liang ;
Ma, Jianping ;
Li, Jingyun ;
Li, Dan ;
Li, Guangming ;
Li, Feng ;
Zhang, Qing ;
Yu, Haisheng ;
Yasui, Fumihiko ;
Ye, Chaobaihui ;
Tsao, Li-Chung ;
Hu, Zhiyuan ;
Su, Lishan ;
Zhang, Liguo .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (01) :269-279
[7]
Maturation of mouse NK cells is a 4-stage developmental program [J].
Chiossone, Laura ;
Chaix, Julie ;
Fuseri, Nicolas ;
Roth, Claude ;
Vivier, Eric ;
Walzer, Thierry .
BLOOD, 2009, 113 (22) :5488-5496
[8]
SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling [J].
Cortez, Victor S. ;
Ulland, Tyler K. ;
Cervantes-Barragan, Luisa ;
Bando, Jennifer K. ;
Robinette, Michelle L. ;
Wang, Qianli ;
White, Andrew J. ;
Gilfillan, Susan ;
Cella, Marina ;
Colonna, Marco .
NATURE IMMUNOLOGY, 2017, 18 (09) :995-+
[9]
Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells [J].
Dadi, Saida ;
Chhangawala, Sagar ;
Whitlock, Benjamin M. ;
Franklin, Ruth A. ;
Luo, Chong T. ;
Oh, Soyoung A. ;
Toure, Ahmed ;
Pritykin, Yuri ;
Huse, Morgan ;
Leslie, Christina S. ;
Li, Ming O. .
CELL, 2016, 164 (03) :365-377
[10]
Type I interferon is selectively required by dendritic cells for immune rejection of tumors [J].
Diamond, Mark S. ;
Kinder, Michelle ;
Matsushita, Hirokazu ;
Mashayekhi, Mona ;
Dunn, Gavin P. ;
Archambault, Jessica M. ;
Lee, Hsiaoju ;
Arthur, Cora D. ;
White, J. Michael ;
Kalinke, Ulrich ;
Murphy, Kenneth M. ;
Schreiber, Robert D. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (10) :1989-2003